weight watcher glp 1 reviews @WeightWatchers is pairing medication with movement, adding @Pvolve classes to its GLP-1 programs., The move reflects a growing push to combine strength training with pharma, especially as muscle loss Weight Watchers Releases GLP-1 Results
Description
Female patients make up nearly 65% of GLP-1 users nationwide, and around 5.2% of women with obesity are prescribed a GLP-1 medication (compared to 4.2% of men)
And, based on the data so far, a significantly larger effect size than anything that came before
Companies such as Amgen (AMG 133 is in mid stage trials), Innovent Biologics and Lilly (Mazdutide, in phase 2 trials) are working on dual agonists for obesity
As always, the most constructive approach is informed, personalized decision-making in conjunction with your healthcare provider(s)
What Comes After Ozempic
